![Rabbit anti-EphA2 Recombinant Monoclonal Antibody [BLR136H]](https://www.axilscientific.com/10808-superlarge_default/rabbit-anti-epha2-recombinant-monoclonal-antibody-blr136h-.jpg)
Rabbit anti-EphA2 Recombinant Monoclonal Antibody [BLR136H]
![Rabbit anti-Occludin Recombinant Monoclonal Antibody [BLR126H]](https://www.axilscientific.com/10799-small_default/rabbit-anti-occludin-recombinant-monoclonal-antibody-blr126h-.jpg)
![Rabbit anti-Slug Recombinant Monoclonal Antibody [BLR139H]](https://www.axilscientific.com/10811-small_default/rabbit-anti-slug-recombinant-monoclonal-antibody-blr139h-.jpg)
Brand:
A700-136-T
- Brand
- Bethyl Laboratories
- Application
- IP
WB
- Storage Conditions
- 2 - 8° C
- Host
- Rabbit
- Conjugation
- Unconjugated
- Immunogen
- residues 25-534 (ECD)
- Buffer
- Borate Buffered Saline (BBS) pH 8.2 with 0.1% BSA and 0.09% Sodium Azide
- Reactivity
- Human
- Target
- EphA2
- Shelf Life
- 1 year from date of receipt
- Antibody Type
- Recombinant Monoclonal
- Alternate Names
- ARCC2, CTPA, CTPP1, CTRCT6, ECK, ephrin type-A receptor 2, Epithelial cell kinase, epithelial cell receptor protein tyrosine kinase, soluble EPHA2 variant 1, tyrosine-protein kinase receptor ECK
- Format
- Whole IgG
- Product Type
- Primary Antibodies
- Product Sub Types
- Primary Antibodies
- UNSPSC
- 12352203
- Western Blot (WB)
- 1:1,000
- Immunoprecipitation (IP)
- 20 µl/1 mg lysate
- Target Sentence
- Ephrin type-A receptor 2 (EphA2) is a member of the Eph family of tyrosine kinase receptors. Eph receptors have been shown to play a critical role in the development of the nervous system, where they regulate patterning during neural development. The ligands for Eph receptors are ephrins. Ephrin receptors and ligands have been found to be frequently overexpressed in a wide variety of cancers. Contrary to the usual finding that the oncogenic properties of tyrosine kinase receptors are promoted by the autophosphorylation of the receptor, it is the dephosphorylation of EphA2 that is associated with its oncogenic activity. The major study of EphA2 has been in relation to its contribution to malignancy and the possibility of targeting it in cancer therapy.
- Product Link
- http://www.bethyl.com/product/A700-136